Conference Coverage

CKD triples risk of bad outcomes in HIV


 

REPORTING FROM CROI


The subjects were all participants in the D:A:D project [Data Collection on Adverse Events of Anti-HIV Drugs], an ongoing international cohort study based at the University of Copenhagen, and funded by pharmaceutical companies, among others.

Dr. Ryom had no disclosures.

SOURCE: Ryom L et al. CROI, Abstract 75.

Pages

Recommended Reading

VIDEO: Women living with HIV have more myocardial steatosis, reduced diastolic function
MDedge Internal Medicine
MDedge Daily News: Can androgen therapy improve male frailty?
MDedge Internal Medicine
Medical marijuana’s ‘Catch-22’: Federal limits on research hinder patients’ relief
MDedge Internal Medicine
Comorbidity occurs earlier and more commonly with HIV infection
MDedge Internal Medicine
HIV infection linked to higher risk of non-melanoma skin cancer
MDedge Internal Medicine
Most HIV patients need treatment for acute HCV
MDedge Internal Medicine
New trial to assess HIV+/HIV+ kidney transplants
MDedge Internal Medicine
Emotional regulation training lowers risk of adolescents having sex
MDedge Internal Medicine
FDA approves epoetin alfa biosimilar to treat anemia
MDedge Internal Medicine
FDA: PrEP indication updated to include adolescents at risk of HIV infection
MDedge Internal Medicine